GovWire

Class 2 Medicines Recall: Sun Pharmaceutical Industries Europe BV, Zoledronic acid SUN 5mg solution for infusion, EL(22)A/34

Medicines Healthcare Products Regulatory Agency

August 11
08:59 2022

MDR number

MDR 054-08/22

Company name

Sun Pharmaceutical Industries Europe BV

Product name

Zoledronic acid SUN 5mg solution for infusion PL 31750/0054

Batch number Expiry date Pack size First distributed
JKX5541B 11/2022 1x100ml vial 15-Jul-2021
HAC1087A 05/2023 1x100ml vial 15-Oct-2021
HAC3395A 08/2023 1x100ml vial 18-Mar-2022
HAD0156B 01/2024 1x100ml vial 17-May-2022

Active Pharmaceutical Ingredient: zoledronic acid (as monohydrate)

Brief description of the problem

Sun Pharmaceuticals are recalling the above batches of zoledronic acid due to out of specification results observed for Particulate Matter Test during routine stability testing.

This recall is conducted as a precautionary measure as remaining vials may no longer be in line with the licensed product specification with respect to particulate matter.

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your suppliers approved process.

If patients felt unwell after the administration of the affected batches above, please report this to the Marketing Authorisation Holder and complete a Yellow Card report via the MHRA Yellow Card scheme.

Advice for patients

  • Patients are not required to take any action at this time. This product is administered by healthcare professionals only. If you have concerns about zoledronic acid that has been given to you, please contact your healthcare professional.
  • The Marketing Authorisation Holder has not received any reports of adverse reactions related to the issue above, however, patients who experience any adverse reactions should seek medical attention. These should also be reported via the MHRA Yellow Card scheme.

Further Information

For more information, medical or supply enquiries, please contact Maciej Rosiak (Qualified Person), +31612091885; maciej.rosiak@sunpharma.com or Gene Kelleher (Head Quality Europe), +353 86 344 1145; gene.kelleher@sunpharma.com.

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Yours faithfully

Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU

Telephone +44 (0)20 3080 6574

DMRC@mhra.gov.uk

Download document

Class 2 Medicines Recall: Sun Pharmaceutical Industries Europe BV, Zoledronic acid SUN 5mg solution for infusion, EL(22)A/34

Published 11 August 2022

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: